Xtandi 40 mg, 112 capsules (Enzalutamide 40 mg per capsule) by Astellas.
Indications: Metastatic and non-metastatic castration-resistant prostate cancer; metastatic hormone-sensitive prostate cancer.
Administration: Oral: 160 mg (4 capsules) once daily.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Astellas |
| Active ingredient | Enzalutamide 40 mg per capsule — androgen receptor inhibitor. |
| Strength & pack | 112 soft capsules. |
| Form | Soft capsules |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |